Mary Elizabeth Gillis is a health reporter and cardiopulmonary specialist with over a decade of experience. After graduating with her doctorate in applied physiology, she earned a master of science degree in journalism from Columbia University.
As childhood obesity rates surge globally, pharma giants test weight loss drugs on kids despite safety concerns over side effects and long-term health impacts.
Taste and smell loss are two symptoms of COVID-19, sometimes lasting years post-infection. New research indicates one drug may reduce duration of such symptoms.
Scientists have yet to uncover the mechanism that causes brain fog in long-COVID patients, but a new study may lead researchers one step closer to the answer.